About this document

Statins vs. PCSK9 Inhibitors: HS Risk Analysis by Syaidahnabilaa is a document available to read on EtoBox.

This meta-analysis compares the risk of hemorrhagic stroke (HS) associated with statins and PCSK9 inhibitors (PCSK9Is). The findings indicate that statins increase HS risk, particularly at higher doses and in patients with prior ischemic events, while PCSK9Is do not show an increased risk. Therefore, PCSK9Is may be a safer lipid-lowering option for patients at elevated HS risk.

Author

Syaidahnabilaa

Language

EN